GlassScriptPhysician profile
Kelly A Fogleman
NPI 1346407137
$7,631.42
in general payments reported to CMS, 2019-2025
47 companies · $825 in 2025
The $825 reported for 2025 was more than what 89% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,236 · 2020: $617 · 2021: $1,316 · 2022: $1,225 · 2023: $1,241 · 2024: $1,171 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,043 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,042.76 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,360.68 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $854.21 | 2021-2025 | Bijuva |
| Novo Nordisk INC | $731.77 | 2019-2025 | Wegovy |
| Astellas Pharma US INC | $669.52 | 2022-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $666.22 | 2019-2024 | Injectafer |
| Exeltis, USA INC. | $376.95 | 2019-2024 | Slynd |
| Evofem Biosciences, INC. | $321.51 | 2020-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $295.02 | 2019-2024 | |
| Organon LLC | $289.90 | 2021-2025 | Nexplanon |
| Mission Pharmacal Company | $187.60 | 2019-2022 | |
| Minerva Surgical, INC | $164.61 | 2019-2023 | |
| Aspira Women'S Health INC | $135.16 | 2022 | |
| Avion Pharmaceuticals | $131.09 | 2019-2022 | |
| Biogen, INC. | $128.81 | 2024-2025 | Zurzuvae |
| Biohaven Pharmaceuticals, INC. | $77.32 | 2021 |
Show all 46 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Fogleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.